Technology And Equipment Tenders

Drug Rebate Contracts with Option to Join - 0004-Rvbeitr.59-2023

Open House Procedure Contract According to § 31 Paragraph 1 and 1A Sgb V on the Supply of Bandages

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Calcium Carbonate and Colecalciferol (A12ax01) as Part of an Open House Model.

Conclusion of Non-Exclusive Discount Agreements According to §§ 130A Abs. 8/130C Abs. 1 Sgb V for Drugs with the Active Ingredient Abatacept (L04aa24) as Part of a So-Called Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Drugs with the Active Ingredient Glatiramer Acetate 40Mg, as a Pre-Filled Pen (L03ax13) as Part of an Open-House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Paragraph 8/130C Paragraph 1 Sgb V for Medicinal Products with the Active Ingredient Macrogol, Combinations (A06ad65) as Part of an Open House Model.

Conclusion of Non-Exclusive Discount Agreements in Accordance with §§ 130A Para. 8/130C Para. 1 Sgb V for Drugs with the Active Ingredient Triptorelin (L02ae04) as Part of a So-Called Open House Model.

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Amifampridine (Atc Code: N07xx05).

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Nitisinone (Atc Code: A16ax04).

Conclusion of a Non-Exclusive Discount Agreement According to Section 130A Paragraph 8 Sgb V for Medicinal Products with the Active Ingredient Dalteparin (Atc Code: B01ab04).